GRAIL, Inc. Debt Securities Available For Sale Excluding Accrued Interest Current
GRAIL, Inc. (GRAL) had Debt Securities Available For Sale Excluding Accrued Interest Current of $805.96 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent · last filed 2026-08-06
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest Current $805.96M.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest Current $753.76M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest Current $654.70M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest Current $413.24M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest Current |
|---|---|
| 2026-06-30 | $805.96M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $753.76M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $654.70M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $413.24M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $475.33M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $540.69M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $549.24M 10-K · filed 2026-03-12 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |